Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 28, 2026
Nucor (NUE) Delivers Strong Q2 Earnings Beat with Record Shipments

Nucor (NUE) Delivers Strong Q2 Earnings Beat with Record Shipments

Key Takeaways

  • Nucor reported adjusted earnings of $4.84 per diluted share, handily surpassing the consensus estimate of approximately $4.38 and exceeding the company's own guidance range of $4.50 to $4.60.
  • Net sales reached $10.40 billion, above Wall Street expectations of roughly $10.14 billion and representing a 23% year-over-year increase from $8.46 billion in the second quarter of 2025.
  • Steel mill shipments hit a record for the second consecutive quarter at 7.1 million tons, with average external pricing rising 7% sequentially to $1,145 per ton.
  • EBITDA (earnings before interest, taxes, depreciation, and amortization) surged to $2.02 billion, a 33% quarter-over-quarter improvement from $1.51 billion in the first quarter of 2026.
  • Management guided for even higher earnings in the third quarter, citing continued pricing momentum across steel mills and steel products segments.
  • Despite the across-the-board beat, Nucor shares traded roughly flat in after-hours trading, suggesting the market had already priced in much of the positive news.

Earnings Context and Why It Matters

Nucor Corporation, the largest steel producer and recycler in North America, entered its second quarter of 2026 riding a wave of favorable trade policy and recovering steel prices. After a challenging 2025 marked by pricing softness and demand headwinds in residential construction, the steel cycle shifted meaningfully in late 2025 and accelerated through the first half of 2026. The Section 232 tariff framework, reinforced by the current administration, has steadily compressed import competition, while demand from data center construction, energy infrastructure, and advanced manufacturing has remained robust. This quarter's results offer a critical read on whether Nucor can sustain its pricing power and volume trajectory in an environment where the policy backdrop is increasingly central to the domestic steel industry's profitability. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Reported Results

Nucor reported consolidated net earnings attributable to stockholders of $1.16 billion, or $5.04 per diluted share, for the second quarter ended July 4, 2026. Adjusted net earnings — which exclude a non-cash, pre-tax benefit of $61 million, or $0.20 per diluted share, related to a markup in the company's investment in fusion energy firm Helion — came in at $1.11 billion, or $4.84 per diluted share. This adjusted figure comfortably exceeded the company's own mid-June guidance of $4.50 to $4.60 and beat the broader analyst consensus, which ranged from approximately $4.37 to $4.57 depending on the data provider.

Net sales totaled $10.40 billion, above the consensus estimate of roughly $10.14 billion and up significantly from $8.46 billion in the prior-year quarter. The steel mills segment was the standout performer, with pre-tax earnings jumping to $1.56 billion from $1.13 billion in the first quarter of 2026 and $843 million in the second quarter of 2025 — an approximately 85% year-over-year increase. The segment benefited from higher average selling prices, record quarterly shipments of 7.1 million tons, and approximately $130 million in cash refunds tied to prior-period raw materials procurement costs. The steel products segment posted pre-tax earnings of $353 million, up from $276 million in the prior quarter, while the raw materials segment contributed $146 million, up from $45 million sequentially.

Free cash flow swung dramatically to positive $829 million, compared to negative $222 million in the same quarter a year ago. The company returned $479 million to shareholders during the quarter through $350 million in share repurchases and $129 million in dividends, while maintaining a conservative debt-to-capital ratio of 23%. Nucor also declared its 213th consecutive quarterly dividend, reinforcing its decades-long commitment to shareholder returns.

Market Reaction and Investor Sentiment

Nucor's second quarter results landed as a clear beat across virtually every metric, yet the stock's after-hours reaction was remarkably subdued — shares slipped approximately 0.2% following the release. This muted response suggests that much of the positive narrative was already reflected in Nucor's stock price, which had surged roughly 71% over the preceding twelve months and approximately 96% over the past year. Earlier earnings reports from peers Steel Dynamics (STLD) and Cleveland-Cliffs (CLF) had already telegraphed the strength in domestic steel pricing and volumes, giving the market ample time to price in favorable conditions. Additionally, Nucor's own mid-June guidance update had narrowed expectations, leaving limited room for a surprise-driven rally. The market's focus now appears to have shifted toward the sustainability of current pricing levels and whether tariff protections will remain intact through the second half of the year.

Forward Outlook and Key Factors to Monitor

Looking ahead, Nucor's management provided an optimistic third-quarter outlook, forecasting higher consolidated earnings compared to the second quarter. The steel mills segment is expected to benefit from further realized pricing improvements across all major product categories, with volumes holding steady. The steel products segment should see gains from both higher volumes and higher pricing, while the raw materials segment may experience a modest pullback due to lower scrap margins.

Several external factors will shape Nucor's trajectory through the remainder of 2026. Trade policy remains the single most important variable. Nucor's own data shows finished carbon and alloy steel import market share falling to approximately 16% in the first half of 2026, down from 21% in 2025 and 23% in 2024. Hot-rolled sheet imports dropped 40% year-over-year under the reinforced Section 232 tariff framework. Any change in enforcement posture could materially alter the competitive landscape.

On the demand side, non-residential construction, data center buildouts, energy infrastructure, and grid modernization continue to provide strong order backlogs. However, residential construction — a key end market — remains subdued due to persistently elevated interest rates, and cyclical industrial markets such as heavy equipment, rail cars, and agriculture continue to show softness. Nucor's diversified end-market exposure across construction, automotive, energy, infrastructure, and manufacturing provides a degree of insulation, but investors should monitor whether pricing momentum can be maintained if broader economic conditions weaken.

The company's capital allocation strategy also warrants attention. With a net debt position that remains conservative and free cash flow generation improving markedly, Nucor retains significant flexibility to continue its share buyback program and maintain its dividend growth streak while funding strategic growth projects. The balance between returning capital to shareholders and investing in long-term capacity expansion will be an ongoing theme for investors to track.

Enhancing Analysis with Tickeron Tools

In my own research process, I frequently rely on Tickeron’s AI Screener to quickly filter opportunities in the steel and industrials space. It helps surface names that match key criteria like pricing trends, volume patterns, and sector signals, allowing me to cross-check ideas beyond the headline numbers. This kind of tool has become a practical addition to traditional fundamental work when evaluating names like Nucor amid shifting trade and demand dynamics.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: NUE

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


NUE's RSI Oscillator ascending out of oversold territory

The RSI Oscillator for NUE moved out of oversold territory on October 01, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 26 similar instances when the indicator left oversold territory. In 24 of the 26 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 36 of 48 cases where NUE's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.

The Momentum Indicator moved above the 0 level on October 05, 2026. You may want to consider a long position or call options on NUE as a result. In 54 of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 72%.

Following a +6.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where NUE advanced for three days, in 267 of 347 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

NUE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for NUE turned negative on September 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 35 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 76%.

NUE moved below its 50-day moving average on September 18, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for NUE crossed bearishly below the 50-day moving average on September 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 53%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NUE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.

The Aroon Indicator for NUE entered a downward trend on October 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 24 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.509) is normal, around the industry mean (2.317). P/E Ratio (19.512) is within average values for comparable stocks, (93.384). Projected Growth (PEG Ratio) (0.020) is also within normal values, averaging (0.339). Dividend Yield (0.009) settles around the average of (0.015) among similar stocks. P/S Ratio (1.657) is also within normal values, averaging (2.301).

The Tickeron Profit vs. Risk Rating rating for this company is 30 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 69, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. NUE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 60 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 63 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

Notable companies

The most notable companies in this group are Nucor Corp (NYSE:NUE), ArcelorMittal (NYSE:MT), Cleveland-Cliffs (NYSE:CLF).

Industry description

The steel industry includes manufacturers of steel and steel-related products. Companies use iron ore and scrap steel to produce steel. The industry also includes companies involved in mining and marketing of steel products. Along with serving some of the domestic markets, U.S. steel output has, over the years, been used by international economies as well. Competition from imported steel has also increased over time. The industry could be susceptible to business cycles, since the element is an important input in industrial production. Some of the globally-renowned steel behemoths include Nucor Corporation, Vale, and ArcelorMittal SA.

Market Cap

The average market capitalization across the Steel Industry is 10.27B. The market cap for tickers in the group ranges from 5K to 55.47B. NUE holds the highest valuation in this group at 55.47B. The lowest valued company is ADTC at 5K.

High and low price notable news

The average weekly price growth across all stocks in the Steel Industry was 3%. For the same Industry, the average monthly price growth was 3%, and the average quarterly price growth was 20%. SID experienced the highest price growth at 12%, while ZKIN experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the Steel Industry was 100%. For the same stocks of the Industry, the average monthly volume growth was 271% and the average quarterly volume growth was 35%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 37
P/E Growth Rating: 29
Price Growth Rating: 50
SMR Rating: 76
Profit Risk Rating: 68
Seasonality Score: 26 (-100 ... +100)
View a ticker or compare two or three
NUE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of steel and steel products

Industry Steel

Industry
Steel
Address
1915 Rexford Road
Phone
+1 704 366-7000
Employees
33000
Web
https://www.nucor.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.